beta-Arrestin 2-mediated heterologous desensitization of IGF-IR by prolonged exposure of SH-SY5Y neuroblastoma cells to a mu opioid agonist

FEBS Lett. 2010 Aug 20;584(16):3580-6. doi: 10.1016/j.febslet.2010.07.025. Epub 2010 Jul 17.

Abstract

Prolonged (12h) exposure of SH-SY5Y neuroblastoma cells to the mu-opioid receptor (MOPr) agonist [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO) causes homologous desensitization as well as heterologous desensitization of the extracellular signal-regulated kinase 1/2 (ERK 1/2) phosphorylation induced by insulin-like growth factor (IGF)-I. Brief (15 min) but not prolonged exposure to DAMGO transregulates the insulin-like growth factor-I (IGF-I) receptor, as evidenced by its phosphorylation in the absence of IGF-I. Silencing of beta-arrestin 2 uncouples the crosstalk between the two receptors, thus maintaining IGF-I-mediated receptor phosphorylation and ERK 1/2 activation even after prolonged DAMGO exposure. Furthermore, MOPr-induced activation of IGF-I receptor requires the tyrosine kinase c-Src.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arrestins / antagonists & inhibitors
  • Arrestins / genetics
  • Arrestins / metabolism*
  • Cell Line, Tumor
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / pharmacology
  • Humans
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Neuroblastoma / genetics
  • Neuroblastoma / metabolism*
  • Phosphorylation
  • RNA, Small Interfering / genetics
  • Receptor Cross-Talk
  • Receptor, IGF Type 1 / genetics
  • Receptor, IGF Type 1 / metabolism*
  • Receptors, Opioid, mu / agonists*
  • Signal Transduction
  • Transcriptional Activation / drug effects
  • beta-Arrestin 2
  • beta-Arrestins

Substances

  • ARRB2 protein, human
  • Arrestins
  • RNA, Small Interfering
  • Receptors, Opioid, mu
  • beta-Arrestin 2
  • beta-Arrestins
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Receptor, IGF Type 1
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3